Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk HLA-A2+ Melanoma”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)WithdrawnNCT01861938
What this trial is testing

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Who this might be right for
High Risk HLA-A2+ MelanomaMetastatic Disease
Hadassah Medical Organization
Testing effectiveness (Phase 2)Looking for participantsNCT01898039
What this trial is testing

Modified Vaccine for High Risk or Low Residual Melanoma Patients

Who this might be right for
Malignant Melanoma
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Ended earlyNCT01495572
What this trial is testing

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00665470
What this trial is testing

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Who this might be right for
Skin CancerMetastatic Melanoma
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Ended earlyNCT00036816
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 13

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation